Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro KwikPen contains four weekly doses, giving you exactly 30 days of treatment. Once you inject your fourth dose, the pen is finished — not because something has gone wrong, but because that's how it was designed. There is no leftover medicine to save for later, and the pen itself cannot be refilled. As a prescription-only medicine, any decision about what comes next belongs to your prescriber, not to you working it out alone. Understanding the 30-day structure helps you plan your supply, manage your expectations around storage, and know exactly when to request your next prescription.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That click (or the resistance you feel when you try to press the button again) is the pen's lock engaging. Mounjaro's KwikPen is engineered to deliver exactly four doses, each at the strength printed on the label. When the fourth dose is gone, a built-in mechanism prevents further use. It is a safety feature, not a manufacturing fault. Some people assume a pen that feels slightly heavier than expected must still have medicine in it; this is one of the most common misconceptions around the format, and it is worth letting go of gently, because trying to extract anything from a used pen is both unsafe and ineffective.
The practical upshot is straightforward: one pen, one month. When you open your packaging from our Mounjaro service, you receive exactly enough for the next 30 days, no more and no less. Planning your next prescription request around that rhythm is the single most useful thing you can do to avoid a gap in treatment.
The NHS patient information for tirzepatide describes both the pen format and the storage conditions you need to respect during those 30 days, worth reading before you start, not after.
Mounjaro arrives refrigerated for a reason. The active molecule, tirzepatide, is a peptide (a short chain of amino acids) and like most biological medicines it degrades faster at room temperature than it does kept cold. Unopened pens must be stored in the fridge at 2–8°C. Once a pen has been used for the first time, or has been kept outside the fridge, a separate time limit begins. The Patient Information Leaflet states the exact figures; the SmPC on the electronic Medicines Compendium gives the same information in clinical detail. Neither document is long and both are freely available.
Why does this matter for the 30-day question? Because if a pen has spent time outside the fridge (say, you took it on a weekend away and forgot to pack your cool bag) the 30-day window may effectively be shorter. The pen does not tell you this. You need to track it yourself. If you are ever uncertain about whether a pen has been stored correctly, contact our prescribers before injecting; using a degraded pen at best wastes a dose and at worst causes unpredictable effects.
Questions about specific storage scenarios come up regularly, and if you are wondering whether Mounjaro can last longer than 30 days under certain conditions, there is a fuller answer on our page about whether Mounjaro goes off after 30 days, covering what the data actually says about medicine stability once the refrigerator chain is broken.
The 30-day structure is inseparable from how Mounjaro is prescribed. It is a prescription-only medicine, which means every supply requires a valid prescription issued by a qualified prescriber following a clinical review. At nume, that review happens before each repeat order, a real clinician reads your update, not an automated queue. No prescription is extended or auto-renewed. This is deliberate: your dose may need to increase as treatment progresses, and weight, tolerance and any new health information all inform that decision.
The titration schedule starts at 2.5mg, with the prescriber moving the dose upward in stages as clinically appropriate. Each stage is its own 30-day pen. If you are considering what continuing Mounjaro after 30 days looks like in practice, the short answer is: the same process repeats, a consultation update, a prescriber review, a fresh prescription if everything checks out, and another pen dispatched.
Timing your request well in advance of running out avoids any break in treatment. Order by 12pm on a working day and, once your prescriber has reviewed and approved your next supply, dispatch goes out the same day with free next-working-day tracked delivery. Allowing a day or two of buffer before your fourth dose is the sensible habit.
A recurring question at this point in treatment is whether carrying on is worth the cost. It is a fair question and one our prescribers hear often. The context that tends to help most: Mounjaro's pricing reflects both the medicine and the clinical infrastructure behind it, including the consultation, the prescription, the pharmacist review, the aftercare, and the delivery. What the market does not always make obvious is how much of that infrastructure disappears when a price looks unusually low. Our page on Mounjaro pricing in the UK walks through what different price points typically do and do not include, without naming names. Worth a read before the next reorder.
If you have a specific clinical question about your current dose or how long you should stay on treatment, the right route is always a conversation with a prescriber rather than a calculation done in isolation. You can start that conversation through our free consultation, or browse our frequently asked questions for answers to common queries first.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.